Cargando…
T49. THE NEURAPRO STUDY: ADHERENCE TO STUDY MEDICATION
BACKGROUND: Adherence to a medication is generally defined as the extent to which patients take medications as prescribed by their health care providers. Poor adherence to study medication is not uncommon posing a major challenge to treatment trails. However, poor adherence may not be randomly distr...
Autores principales: | Schlögelhofer, Monika, McGorry, Patrick D, Nelson, Barnaby, Markulev, Connie, Yuen, Hok Pan, Schäfer, Miriam, Mossaheb, Nilufar, Smesny, Stefan, Hickie, Ian B, Berger, Gregor, Chen, Eric Y H, de Haan, Lieuwe, Nieman, Dorien H, Nordentoft, Merete, Riecher-Rössler, Anita, Verma, Swapna, Thompson, Andrew, Yung, Alison Ruth, Paul Amminger, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888024/ http://dx.doi.org/10.1093/schbul/sby016.325 |
Ejemplares similares
-
T9. CROSS-SECTIONAL ASSOCIATION OF MEMBRANE FATTY ACID COMPOSITION AND PSYCHOPATHOLOGY IN THE NEURAPRO-E STUDY
por: Berger, Maximus, et al.
Publicado: (2018) -
T34. THE IMPACT OF ANTIDEPRESSANT USE ON THE TRANSITION TO PSYCHOSIS RATE IN THE NEURAPRO TRIAL
por: Schlögelhofer, Monika, et al.
Publicado: (2020) -
O8.8. NEUROCOGNITION IN ULTRA-HIGHRISK INDIVIDUALS AND RELATIONSHIP TO TRANSITION TO PSYCHOSIS, DEPRESSIVE DISORDER, AND FUNCTIONING: FINDINGS FROM THE NEURAPRO TRIAL
por: Allott, Kelly, et al.
Publicado: (2018) -
F25. NEURAPRO REVISITED: INCREASES IN LONG-CHAIN OMEGA-3 FATTY ACIDS IMPROVE FUNCTIONAL AND SYMPTOMATIC OUTCOMES IN ULTRAHIGH RISK PATIENTS
por: Paul Amminger, G, et al.
Publicado: (2018) -
Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial
por: Berger, Maximus, et al.
Publicado: (2019)